| Degarelix studied in …STUDIED_INderived106 of 106show fewer |
|---|
| → studied in | NCT03070886Phase 2/Phase 3 · active not recruiting Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery · 106 trials list this drug (23 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07335796Phase 2 · active not recruiting A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02005887Phase 2 · completed TRial on the Endocrine Activity of Neoadjuvant Degarelix · 106 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05501704Phase 2 · recruiting ETHAN - ET for Male BC · 106 trials list this drug (23 active) | — | — | Male Breast Carcinoma,Hormone Receptor-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04423211Phase 3 · recruiting Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging · 106 trials list this drug (23 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04513717Phase 3 · active not recruiting Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial · 106 trials list this drug (23 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05050084Phase 3 · active not recruiting Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial · 106 trials list this drug (23 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01786265Phase 2 · active not recruiting Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer · 106 trials list this drug (23 active) | — | — | Prostate Adenocarcinoma,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07455903Phase 2 · recruiting Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01542021NA · completed Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06378866Phase 2 · recruiting Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma,Castration-Sensitive Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02020070Phase 2 · completed Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy · 106 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02346253NA · completed High-Dose Brachytherapy in Treating Patients With Prostate Cancer · 106 trials list this drug (23 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04989946Phase 1/Phase 2 · active not recruiting Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05617885Phase 1 · completed Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05873192Phase 2 · recruiting Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02799706Phase 3 · active not recruiting Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03361735Phase 2 · active not recruiting Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer · 106 trials list this drug (23 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05839119Phase 1 · terminated Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant · 106 trials list this drug (23 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03947151Phase 2 · completed Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer · 106 trials list this drug (23 active) | — | — | Invasive Breast Carcinoma of No Special Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06282588Phase 2/Phase 3 · recruiting Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04455750Phase 3 · active not recruiting A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy · 106 trials list this drug (23 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05701007completed Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland · 106 trials list this drug (23 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04734730Phase 2 · recruiting Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer · 106 trials list this drug (23 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Castration-Sensitive Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01746849Phase 2 · active not recruiting Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation · 106 trials list this drug (23 active) | — | — | Leukemia,Multiple Myeloma,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00117286Phase 2/Phase 3 · completed Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03069937Phase 2 · completed Phase II Study of Docetaxel Before Degarelix in Patients With Newly Diagnosed Metastatic Prostate Cancer. · 106 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03678025Phase 3 · recruiting Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01990196Phase 2 · active not recruiting Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04301414early Phase 1 · completed Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02278185Phase 2 · completed Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer · 106 trials list this drug (23 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03689699Phase 1/Phase 2 · active not recruiting Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8) · 106 trials list this drug (23 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03951831Phase 2 · active not recruiting REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer · 106 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01220869Phase 3 · completed A Study of Degarelix in Taiwanese Patients With Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05917860Phase 1 · active not recruiting Neoadjuvant ADT with TULSA in the Treatment of Intermediate Risk Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01261572Phase 2 · completed Study to Find Maintenance Dose for Periodic Administration of ASP3550 · 106 trials list this drug (23 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01964170Phase 3 · completed A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06218667Phase 1/Phase 2 · withdrawn A Study of Copanlisib in Combination with Degarelix in People with Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03056638Phase 3 · terminated Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03080116Phase 2 · unknown Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03358563early Phase 1 · completed Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03899077Phase 2 · unknown Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04176081Phase 2 · not yet recruiting Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00818623Phase 2 · completed Investigation of a New Trial Drug (FE200486) in Prostate Cancer Patients · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00819156Phase 2 · completed Dose Finding Trial With a New Treatment (Degarelix) for Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00819247Phase 2 · completed The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01377389Phase 2 · terminated Ipilimumab + Androgen Depravation Therapy in Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04897958completed Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims Data · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02015871Phase 3 · completed An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04282876unknown Influence of Hormone Treatment in Radiation Therapy for Bladder Cancer · 106 trials list this drug (23 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02663908Phase 3 · terminated A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05212857Phase 2 · unknown Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02849990Phase 2 · completed A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy · 106 trials list this drug (23 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02726009Phase 4 · completed A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01751451Phase 2 · completed 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02489357NA · completed Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04248621Phase 4 · unknown Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients · 106 trials list this drug (23 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04585932Phase 2 · withdrawn Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm,Oligometastatic Prostate Carcinoma,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01545882Phase 2 · terminated A Phase II Study of Degarelix in the Management of Non-Metastatic Hormone-Refractory Prostate Cancer · 106 trials list this drug (23 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01710098completed Treatment of Prostate Cancer With Firmagon® · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01446991Phase 2 · completed Feasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate Brachytherapy · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04134130NA · completed The Role of Follicle Stimulating Hormone in Advanced Prostate Cancer · 106 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04182594Phase 2 · unknown Cardiovascular Events in GnRH Agonist vs. Antagonist · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01512472Phase 4 · terminated Firmagon (Degarelix) Intermittent Therapy · 106 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02324998Phase 1 · completed Study of Olaparib (± Degarelix) Given to Men With Intermediate/High Risk Prostate Cancer Before Prostatectomy · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02234089completed Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists. · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02886598completed Safety and Efficacy of Firmagon® (Degarelix) for Injection · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02475057Phase 4 · completed Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists · 106 trials list this drug (23 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01696877Phase 1/Phase 2 · completed A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer · 106 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03193645completed Observational Prospective Study Describing the Global Patient Care and Follow-up of Prostate Cancer Patients Treated With Degarelix · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01731912NA · completed Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer · 106 trials list this drug (23 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02560051Phase 2 · terminated Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer · 106 trials list this drug (23 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02494713Phase 2 · terminated Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01861236completed Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina · 106 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02229253completed Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate Cancer · 106 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02468284Phase 1 · completed Pharmacokinetics of Degarelix in Chinese Patients With Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02526784Phase 3 · completed A Trial Evaluating Two Subcutaneous Injection Techniques and Intramuscular Administration of Degarelix in Patients With Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03202381Phase 4 · unknown Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelix · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02135445Phase 2 · completed Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00928434Phase 3 · completed A Study of Degarelix in Patients With Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01674270Phase 2 · completed Degarelix Neo-Adjuvant Radical Prostatectomy Trial · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01744366Phase 3 · completed One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01242748Phase 3 · terminated A Degarelix Trial in Patients With Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00215683Phase 2/Phase 3 · completed An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02159690Phase 2 · withdrawn A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00801242Phase 3 · completed Intermittent Treatment With Degarelix of Patients Suffering From Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00946920Phase 3 · completed A Trial of Degarelix in Patients With Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01491971Phase 2 · completed Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00884273Phase 3 · completed Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00831233Phase 3 · terminated Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01215513Phase 3 · completed Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01071915Phase 3 · completed Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00738673Phase 2 · completed Degarelix as Second-Line Hormonal Treatment After Prostate-specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00967018Phase 3 · completed A Long Term Safety Study of Degarelix in Patients With Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00295750Phase 3 · completed The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00833248Phase 3 · completed Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01630967Phase 2 · unknown Efficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to Treat Progressive Castrate Resistant Prostate Cancer (CRPC) · 106 trials list this drug (23 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00116779Phase 2 · completed A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00117312Phase 2 · terminated Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00117949Phase 2 · completed Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486 · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00215657Phase 2 · terminated Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00245466Phase 2 · terminated Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00468286Phase 2 · completed Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00728533Phase 3 · withdrawn Open-Label, Randomised Parallel-Group Study · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00268892Phase 2/Phase 3 · completed Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00116753Phase 2 · completed A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer · 106 trials list this drug (23 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |